US-based DaVita HealthCare Partners has signed an agreement to acquire Colorado-based Renal Ventures for $415m.
Renal Ventures runs 36 dialysis clinics in six US states.
The firm’s divisions, including Multispecialty Physician Partners and Physician Venture Partners, operate infusion and vascular centres in three states.
DaVita Kidney Care CEO Javier Rodriguez said: "We are excited to work with Renal Ventures’ patients, employees and physicians.
"Our commitment is, and will always be about enhancing the quality of life for our patients."
Renal Ventures CEO Larry Chatfield said: "Renal Ventures takes great pride in its culture of actively engaging our employees, patients and the communities we serve.
"In today’s changing healthcare environment, combining with DaVita, a patient-centric organisation, will benefit all of our stakeholders."
Credit Suisse served as financial advisor to DaVita, while Morrison & Foerster acted as lead counsel and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo acted as regulatory counsel to DaVita.
For Renal Ventures, Brownstein Hyatt Farber Schreck acted as lead counsel and Raymond James and Associates served as financial advisor.
DaVita Kidney Care, part of DaVita HealthCare Partners, provides a variety of healthcare services to patient populations across the US and abroad.
It operates 2,306 outpatient dialysis centres, of which 2,210 centres are situated in the US and 96 centres are located in ten countries outside the US.